Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kishori R. Gaikwad"'
Publikováno v:
Journal of Pharmaceutical Sciences and Pharmacology. 1:101-111
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7cba5df1636647f04735cf5e03ed79bb
https://doi.org/10.1166/jpsp.2014.1015
https://doi.org/10.1166/jpsp.2014.1015
Publikováno v:
World Journal of Cancer Research. 1:50-60
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6ad75cdc3ccce37f9f690b7789d03ec
https://doi.org/10.1166/wjcr.2013.1007
https://doi.org/10.1166/wjcr.2013.1007
Publikováno v:
European Journal of Drug Metabolism and Pharmacokinetics. 37:117-123
The field of ocular drug delivery is one of the interesting and challenging endeavors facing the pharmaceutical scientist. Novel approaches for ophthalmic drug delivery need to be established to increase the ocular bioavailability by overcoming the i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::808813baee1bd2427fd12d9201dc4bfd
https://doi.org/10.1007/s13318-011-0070-9
https://doi.org/10.1007/s13318-011-0070-9
Publikováno v:
PDA journal of pharmaceutical science and technology. 65(5)
Pulmonary drug delivery is a developing technology in which medication is inhaled through the lungs and enters the bloodstream through the alveolar epithelium. Pulmonary drug delivery provides a noninvasive, alternative method to subcutaneous injecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bef196e36aef09207963091a280948c3
https://pubmed.ncbi.nlm.nih.gov/22293840
https://pubmed.ncbi.nlm.nih.gov/22293840
Autor:
F. V. Manvi, Veerendra K. Nanjwade, Sachin A. Thakare, Sagar A Adichwal, Basavaraj K. Nanjwade, Kishori R. Gaikwad
Publikováno v:
Journal of Drug Metabolism & Toxicology. 3
The purpose of this research was to develop a novel gastroretentive drug delivery system based on effervescent technology for controlled delivery of active agent. Glipizide, a poorly soluble drug has been used as a model drug and an attempt has been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fb2bc858a405b5748199e30781504046
https://doi.org/10.4172/2157-7609.1000121
https://doi.org/10.4172/2157-7609.1000121
Autor:
Rucha V. Deshmukh, Kemy A. Parikh, F. V. Manvi, Basavaraj K. Nanjwade, Kishori R. Gaikwad, Sachin A. Thakare, Veerendra K. Nanjwade
Publikováno v:
Pharmaceutica Analytica Acta.
Purpose: Neostigmine bromide, a cholinesterase inhibitor is conventionally given by oral route for the treatment of myasthenia gravis. However, it is very poorly absorbed from gastro-intestinal tract. Intranasal administration is an ideal alternative
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b8953866c52270f25c08dc010cffec03
https://doi.org/10.4172/2153-2435.1000118
https://doi.org/10.4172/2153-2435.1000118